{{Rsnum
|rsid=2280673
|Gene=RAB6B
|Chromosome=3
|position=133839310
|Orientation=plus
|GMAF=0.4408
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=RAB6B
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 12.5 | 42.9 | 44.6
| HCB | 29.9 | 56.9 | 13.1
| JPT | 27.7 | 46.4 | 25.9
| YRI | 17.9 | 51.0 | 31.0
| ASW | 8.8 | 57.9 | 33.3
| CHB | 29.9 | 56.9 | 13.1
| CHD | 41.3 | 44.0 | 14.7
| GIH | 34.7 | 47.5 | 17.8
| LWK | 14.5 | 50.0 | 35.5
| MEX | 29.3 | 50.0 | 20.7
| MKK | 17.1 | 50.0 | 32.9
| TSI | 12.7 | 49.0 | 38.2
| HapMapRevision=28
}}
{{PMID|19084217|OA=1
}} Relevant to [[Hemochromatosis]]

{{omim
|desc=TRANSFERRIN; TF
|id=190000
|rsnum=2280673
}}

{{PharmGKB
|RSID=rs2280673
|Name_s=
|Gene_s=RAB6B
|Feature=
|Evidence=PubMed ID:19084217
|Annotation=In a GWAS performed on 459 female monozygotic twin pairs, all Australians of European descent, this SNP was found to be significantly associated with serum transferrin (p = 2.3 x 10 (-4)).
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA164920575
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2280673
|overall_frequency_n=70
|overall_frequency_d=128
|overall_frequency=0.546875
|n_genomes=45
|n_genomes_annotated=0
|n_haplomes=60
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}